Chung Hsing Chemical Announces Board Approval of 115 Q2 Consolidated Financial Report

1. Date reported to or resolved by the Board of Directors: 115/08/11 2. Audit Committee approval date: 115/08/11 3. Reporting period for financial report or self-compiled annual financial information: Start and end date (XXX/XX/XX~XXX/XX/XX): 115/01/01~115/06/30 4. Cumulative operating revenue from January 1 to end of reporting period (in thousand NT$): 6,759,902 5. Cumulative operating gross profit (loss) from January 1 to end of reporting period (in thousand NT$): (774,478) 6. Cumulative operating income (loss) from January 1 to end of reporting period (in thousand NT$): (1,380,482) 7. Cumulative pre-tax net profit (loss) from January 1 to end of reporting period (in thousand NT$): (1,447,549) 8. Net profit (loss) for the period from January 1 to end of reporting period (in thousand NT$): (1,567,268) 9. Net profit (loss) attributable to owners of parent from January 1 to end of reporting period (in thousand NT$): (1,276,655) 10. Cumulative basic earnings (loss) per share from January 1 to end of reporting period (in NT$): (1.32) 11. Total assets at end of period (in thousand NT$): 48,204,714 12. Total liabilities at end of period (in thousand NT$): 24,069,644 13. Equity attributable to owners of parent at end of period (in thousand NT$): 23,034,043 14. Other matters to be disclosed: None